GeoVax Labs (GOVX) – Get Report stock surged on Friday after the biotech presented data from studies of its preventive vaccine that it said validate its approach to addressing COVID-19 and its variants.
Shares of the Smyrna, Ga., company at last check were 36% higher at $5.86.
Mark Newman, the company's chief scientific officer, made the presentation virtually during the European Society of Medicine General Assembly in Berlin.
The company said it intended to induce broader immunity against variants by including multiple structural....More>>>